Peter D R Higgins Selected Research

Stents

1/2015	The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement.
3/2013	Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter D R Higgins Research Topics

Disease

28	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2022 - 08/2008
27	Crohn Disease (Crohn's Disease) 01/2022 - 02/2009
24	Fibrosis (Cirrhosis) 01/2022 - 04/2011
21	Ulcerative Colitis 01/2022 - 09/2008
21	Inflammation (Inflammations) 01/2022 - 12/2005
12	Infections 10/2022 - 01/2010
11	Colitis 01/2021 - 02/2011
9	Neoplasms (Cancer) 01/2021 - 12/2005
8	Pathologic Constriction (Stenosis) 01/2022 - 03/2007
6	Necrosis 10/2022 - 12/2012
4	Hemorrhage 01/2022 - 01/2011
4	Pancreatitis 01/2020 - 04/2012
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2020
2	Herpes Zoster 01/2021 - 01/2020
2	Human Influenza (Influenza) 01/2021 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 06/2015
2	Gastrointestinal Hemorrhage (Hematochezia) 01/2017 - 05/2005
2	Intestinal Diseases (Diseases, Intestinal) 01/2017 - 01/2016
2	Clostridium Infections 09/2016 - 07/2012
2	Venous Thromboembolism 01/2016 - 01/2016
2	Hepatitis C 06/2015 - 11/2013
2	Idiopathic Pulmonary Fibrosis 04/2015 - 10/2012
2	Colonic Neoplasms (Colon Cancer) 11/2010 - 05/2005
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2006 - 12/2005
2	Colorectal Neoplasms (Colorectal Cancer) 12/2005 - 05/2005
1	Skin Neoplasms (Skin Cancer) 11/2022
1	COVID-19 10/2022
1	Intestinal Obstruction (Obstruction, Intestinal) 06/2022
1	Nasopharyngitis 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Acne Vulgaris 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Osteoporosis 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Intestinal Failure 01/2021

Drug/Important Bio-Agent (IBA)

11	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 02/2015
9	Pharmaceutical PreparationsIBA 01/2022 - 10/2006
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2007
8	Biological ProductsIBA 01/2022 - 10/2006
8	SteroidsIBA 01/2022 - 03/2007
6	tofacitinibIBA 10/2021 - 01/2017
5	Monoclonal AntibodiesIBA 01/2022 - 12/2012
4	CytokinesIBA 01/2021 - 06/2011
4	Mesalamine (Mesalazine)FDA LinkGeneric 01/2021 - 02/2009
4	Indomethacin (Indometacin)FDA LinkGeneric 01/2020 - 04/2012
4	Sulfonic AcidsIBA 05/2019 - 09/2011
4	Proteins (Proteins, Gene)FDA Link 06/2017 - 12/2005
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2010 - 05/2005
3	vedolizumabIBA 10/2022 - 12/2013
3	InterleukinsIBA 01/2022 - 12/2012
3	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 07/2017
3	Janus Kinase InhibitorsIBA 10/2021 - 01/2019
3	Infliximab (Remicade)FDA Link 01/2020 - 11/2012
3	C-Reactive ProteinIBA 01/2019 - 10/2017
3	2-mercaptopurineIBA 07/2017 - 02/2010
2	Opioid Analgesics (Opioids)IBA 12/2022 - 01/2019
2	VaccinesIBA 10/2022 - 01/2021
2	Interleukin-23 (Interleukin 23)IBA 01/2022 - 07/2017
2	Ustekinumab (CNTO 1275)FDA Link 01/2022 - 01/2019
2	Adalimumab (Humira)FDA Link 01/2022 - 12/2018
2	Extracellular Matrix ProteinsIBA 01/2022 - 06/2017
2	Janus Kinase 1IBA 01/2022 - 01/2020
2	upadacitinibIBA 01/2022 - 01/2020
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2010
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2020 - 09/2019
2	EnzymesIBA 01/2019 - 04/2012
2	Narcotics (Narcotic Analgesics)IBA 12/2018 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2018 - 10/2017
2	N- (4- chlorophenyl)- 1- ((3- (furan- 2- yl)phenyl)carbonyl)piperidine- 3- carboxamideIBA 06/2017 - 04/2015
2	Ethanol (Ethyl Alcohol)IBA 03/2017 - 03/2012
2	CollagenIBA 03/2017 - 07/2016
2	Phenobarbital (Luminal)FDA Link 01/2017 - 02/2011
2	Hemoglobins (Hemoglobin)IBA 01/2017 - 07/2016
2	InterferonsIBA 01/2017 - 06/2015
2	AlbuminsIBA 01/2017 - 01/2016
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 09/2016 - 12/2012
2	Trinitrobenzenesulfonic AcidIBA 09/2015 - 06/2013
2	Antiviral Agents (Antivirals)IBA 06/2015 - 11/2013
2	Fibronectins (Fibronectin)IBA 06/2015 - 04/2015
2	Vitamin D FDA LinkGeneric 01/2015 - 08/2012
1	Interleukin-12 (IL 12)IBA 01/2022
1	etrolizumabIBA 01/2022
1	mirikizumabIBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	BH 3IBA 01/2022
1	navitoclaxIBA 01/2022

Therapy/Procedure

42	Therapeutics 11/2022 - 09/2008
5	Colectomy 10/2021 - 02/2009
5	Biological Therapy 01/2019 - 02/2011
4	Enema (Enemas) 03/2017 - 09/2011
3	Liver Transplantation 01/2017 - 11/2013
2	Aftercare (After-Treatment) 01/2020 - 01/2020
2	Stents 01/2015 - 03/2013
2	Secondary Prevention 12/2013 - 10/2006
2	Surgical Instruments (Clip) 08/2011 - 08/2008
2	Chemoprevention 11/2010 - 02/2009
1	Catheters 06/2022
1	Remission Induction 01/2022